Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group

Ayano Kelly; Susan J. Bartlett; Maarten P. De Wit; Dorcas E. Beaton; Therese Dawson; Vicki Evans; Michael Gill; Geraldine Hassett; Lyn March; Marieke Scholte-Voshaar; Jasvinder A. Singh; Allison Tong; Peter Tugwell; Peter Wong; Kathleen Tymms

doi:10.3899/jrheum.181078

Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group

Ayano Kelly^*, Susan J. Bartlett, Maarten P. De Wit, Dorcas E. Beaton, Therese Dawson, Vicki Evans, Michael Gill, Geraldine Hassett, Lyn March, Marieke Scholte-Voshaar, Jasvinder A. Singh, Allison Tong, Peter Tugwell, Peter Wong, Kathleen Tymms

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

Objective. The OMERACT-Adherence meeting was convened to discuss the conceptual and methodological challenges in developing a core domain set (Adherence-CDS) for trials of interventions for medication adherence in rheumatology. Methods. Forty participants from nine countries participated. Results. Four ideas emerged: for adherence trials, the Adherence-CDS could include adherence and the condition-specific CDS; many factors affect adherence and are intervention targets, contextual factors, or outcome domains; adherence is a critical factor in drug trials; and standardized adherence measures are needed. Conclusion. Despite the challenges, the meeting clarified an approach to developing an Adherence-CDS that complements existing OMERACT work and methodology.

Original language	English
Pages (from-to)	1202-1206
Number of pages	5
Journal	Journal of Rheumatology
Volume	46
Issue number	9
DOIs	https://doi.org/10.3899/jrheum.181078
Publication status	Published - 1 Sept 2019

Access to Document

10.3899/jrheum.181078

Cite this

Kelly, A., Bartlett, S. J., De Wit, M. P., Beaton, D. E., Dawson, T., Evans, V., Gill, M., Hassett, G., March, L., Scholte-Voshaar, M., Singh, J. A., Tong, A., Tugwell, P., Wong, P., & Tymms, K. (2019). Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group. Journal of Rheumatology, 46(9), 1202-1206. https://doi.org/10.3899/jrheum.181078

@article{7418dc75d84247eba10bf586ddc1d773,

title = "Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group",

abstract = "Objective. The OMERACT-Adherence meeting was convened to discuss the conceptual and methodological challenges in developing a core domain set (Adherence-CDS) for trials of interventions for medication adherence in rheumatology. Methods. Forty participants from nine countries participated. Results. Four ideas emerged: for adherence trials, the Adherence-CDS could include adherence and the condition-specific CDS; many factors affect adherence and are intervention targets, contextual factors, or outcome domains; adherence is a critical factor in drug trials; and standardized adherence measures are needed. Conclusion. Despite the challenges, the meeting clarified an approach to developing an Adherence-CDS that complements existing OMERACT work and methodology.",

keywords = "Omeract, Outcome assessment (healthcare), Rheumatic diseases, Treatment adherence and compliance",

author = "Ayano Kelly and Bartlett, {Susan J.} and {De Wit}, {Maarten P.} and Beaton, {Dorcas E.} and Therese Dawson and Vicki Evans and Michael Gill and Geraldine Hassett and Lyn March and Marieke Scholte-Voshaar and Singh, {Jasvinder A.} and Allison Tong and Peter Tugwell and Peter Wong and Kathleen Tymms",

year = "2019",

month = sep,

day = "1",

doi = "10.3899/jrheum.181078",

language = "English",

volume = "46",

pages = "1202--1206",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "9",

}

Kelly, A, Bartlett, SJ, De Wit, MP, Beaton, DE, Dawson, T, Evans, V, Gill, M, Hassett, G, March, L, Scholte-Voshaar, M, Singh, JA, Tong, A, Tugwell, P, Wong, P & Tymms, K 2019, 'Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group', Journal of Rheumatology, vol. 46, no. 9, pp. 1202-1206. https://doi.org/10.3899/jrheum.181078

TY - JOUR

T1 - Addressing challenges in developing a core domain set in adherence interventions in rheumatology

T2 - A report from the OMERACT-Adherence Group

AU - Kelly, Ayano

AU - Bartlett, Susan J.

AU - De Wit, Maarten P.

AU - Beaton, Dorcas E.

AU - Dawson, Therese

AU - Evans, Vicki

AU - Gill, Michael

AU - Hassett, Geraldine

AU - March, Lyn

AU - Scholte-Voshaar, Marieke

AU - Singh, Jasvinder A.

AU - Tong, Allison

AU - Tugwell, Peter

AU - Wong, Peter

AU - Tymms, Kathleen

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Objective. The OMERACT-Adherence meeting was convened to discuss the conceptual and methodological challenges in developing a core domain set (Adherence-CDS) for trials of interventions for medication adherence in rheumatology. Methods. Forty participants from nine countries participated. Results. Four ideas emerged: for adherence trials, the Adherence-CDS could include adherence and the condition-specific CDS; many factors affect adherence and are intervention targets, contextual factors, or outcome domains; adherence is a critical factor in drug trials; and standardized adherence measures are needed. Conclusion. Despite the challenges, the meeting clarified an approach to developing an Adherence-CDS that complements existing OMERACT work and methodology.

AB - Objective. The OMERACT-Adherence meeting was convened to discuss the conceptual and methodological challenges in developing a core domain set (Adherence-CDS) for trials of interventions for medication adherence in rheumatology. Methods. Forty participants from nine countries participated. Results. Four ideas emerged: for adherence trials, the Adherence-CDS could include adherence and the condition-specific CDS; many factors affect adherence and are intervention targets, contextual factors, or outcome domains; adherence is a critical factor in drug trials; and standardized adherence measures are needed. Conclusion. Despite the challenges, the meeting clarified an approach to developing an Adherence-CDS that complements existing OMERACT work and methodology.

KW - Omeract

KW - Outcome assessment (healthcare)

KW - Rheumatic diseases

KW - Treatment adherence and compliance

UR - http://www.scopus.com/inward/record.url?scp=85071756771&partnerID=8YFLogxK

U2 - 10.3899/jrheum.181078

DO - 10.3899/jrheum.181078

M3 - Article

SN - 0315-162X

VL - 46

SP - 1202

EP - 1206

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 9

ER -

Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group

Abstract

Access to Document

Other files and links

Fingerprint

Cite this